Nihat Okçu
Research Subjects
Nihat Okçu has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Erdoğan Şeyran
Van Training and Research Hospital, University of Health Sciences, Van 65300, Türkiye
1 shared publication - Ömer Topdağı
Bahçeşehir Üniversitesi
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 6 (1) , 11-16
Serum Procalcitonin for the Diagnosis of Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis: A Prospective Study
Objectives: Spontaneous bacterial peritonitis (SBP) is a serious infectious complication in patients with decompensated cirrhosis. Although serum procalcitonin (PCT) has been evaluated as a potential indicator of bacterial infection, its clinical value in the diagnosis of SBP remains uncertain. This study investigated the diagnostic contribution of serum procalcitonin in cirrhotic patients with SBP. Methods: This prospective, single-center study included 100 participants: 50 patients with SBP, 25 patients with sterile ascites, and 25 healthy controls. The diagnosis of SBP was established according to the ascitic fluid polymorphonuclear leukocyte (PMNL) count and/or positive ascitic fluid culture findings. Serum procalcitonin levels and ascitic inflammatory parameters were compared among the study groups. Results: Serum procalcitonin levels were numerically higher in patients with SBP than in patients with sterile ascites and healthy controls; however, the differences were not statistically significant (p>0.05). In contrast, ascitic fluid leukocyte and PMNL counts were significantly elevated in the SBP group (p
- 1 January 2026
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 6 (1) , 11-16
Open AccessSerum Procalcitonin for the Diagnosis of Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis: A Prospective Study
Objectives: Spontaneous bacterial peritonitis (SBP) is a serious infectious complication in patients with decompensated cirrhosis. Although serum procalcitonin (PCT) has been evaluated as a potential indicator of bacterial infection, its clinical value in the diagnosis of SBP remains uncertain. This study investigated the diagnostic contribution of serum procalcitonin in cirrhotic patients with SBP. Methods: This prospective, single-center study included 100 participants: 50 patients with SBP, 25 patients with sterile ascites, and 25 healthy controls. The diagnosis of SBP was established according to the ascitic fluid polymorphonuclear leukocyte (PMNL) count and/or positive ascitic fluid culture findings. Serum procalcitonin levels and ascitic inflammatory parameters were compared among the study groups. Results: Serum procalcitonin levels were numerically higher in patients with SBP than in patients with sterile ascites and healthy controls; however, the differences were not statistically significant (p>0.05). In contrast, ascitic fluid leukocyte and PMNL counts were significantly elevated in the SBP group (p